文献速递白内障与屈光手术青光眼眼底病与葡萄膜炎

COVID-19 大流行与 Medicare 受益人常见眼科手术率的变化

COVID-19 Pandemic and Rates of Common Ophthalmic Procedures Among Medicare Beneficiaries.
PubMed 文献 · JAMA Ophthalmol · 2025-01-01

这项回顾性美国横断面研究比较了 2019 与 2020 年 Medicare Part B 全国汇总数据中 10 种最常见眼科手术的数量,2019 年共 3 879 533 条手术记录、2020 年共 3 181 439 条。结果显示 10 种手术总体下降 -17.9%(99% CI,-24.8% 至 -11.3%),激光周边虹膜切开术降幅最大(-43.6%),眼内药物注射降幅最小(-1.5%),白内障手术下降 -23.0%,东北部白内障手术降幅最大(-27.9%)。

要点

  • 10 种最常见眼科手术总体下降 -17.9%(99% CI,-24.8% 至 -11.3%)。
  • 激光周边虹膜切开术降幅最大(-43.6%;99% CI,-51.7% 至 -31.9%)。
  • 眼内药物注射降幅最小(-1.5%;99% CI,-3.3% 至 0.3%),白内障手术下降 -23.0%。

核心结论

  • COVID-19 大流行导致 Medicare 受益人常见眼科手术数量显著下降,激光周边虹膜切开术降幅最大而眼内药物注射变化最小,东北部降幅最大,提示疫情与眼科诊疗变化相关并需在受冲击最重地区重点恢复。

研究设计与样本

  • 回顾性美国横断面研究,比较 Medicare Part B 全国汇总数据文件中 2019 与 2020 日历年的数据,纳入接受 10 种最常见眼科手术的 Medicare 受益人,2019 年共 3 879 533 条手术记录、2020 年共 3 181 439 条,数据分析时间为 2019 年 1 月 1 日至 2020 年 12 月 31 日。

主要发现

  • 2019 至 2020 年 10 种眼科手术总体下降 -17.9%(99% CI,-24.8% 至 -11.3%)。
  • 激光周边虹膜切开术降幅最大,为 -43.6%(99% CI,-51.7% 至 -31.9%)。
  • 眼内药物注射降幅最小,为 -1.5%(99% CI,-3.3% 至 0.3%)。
  • 白内障手术下降 -23.0%(99% CI,-28.8% 至 -18.7%)。
  • 东北部白内障手术降幅最大,为 -27.9%(99% CI,-32.8% 至 -22.3%)。

临床怎么用

  • 原文结论指出疫情与眼科诊疗变化相关,并提示需在受冲击最重地区重点开展恢复工作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The COVID-19 pandemic has altered health care delivery, including ophthalmic care. Understanding how the pandemic has changed the rates of commonly performed ophthalmic procedures is crucial for assessing the broader implications for patient care and resource allocation. OBJECTIVE: To estimate the changes in the rates of the 10 most prevalent ophthalmic procedures among Medicare beneficiaries during the COVID-19 pandemic and to explore the geographic disparities in these shifts. DESIGN: This retrospective US cross-sectional study compared data from Medicare Part B National Summary Data Files for the calendar years 2019 and 2020. Participants included Medicare beneficiaries undergoing the 10 most common ophthalmic procedures. Data included a total of 3 879 533 procedure entries in 2019 and 3 181 439 entries in 2020. Data were analyzed from January 1, 2019, to December 31, 2020. EXPOSURE: COVID-19 pandemic. MAIN OUTCOMES AND MEASURES: The primary outcome was the percentage change in the number of beneficiaries for each of the 10 most common ophthalmic procedures in each state. RESULTS: There was an overall decrease of -17.9% in the rates of the 10 ophthalmic procedures from 2019 to 2020 (99% CI, -24.8% to -11.3%). The largest reduction was observed in laser peripheral iridotomy (-43.6%; 99% CI, -51.7% to -31.9%), while eye drug injections saw the smallest decrease (-1.5%; 99% CI, -3.3% to 0.3%). Cataract surgery also saw a reduction of -23.0% (99% CI, -28.8% to -18.7%). Regionally, the Northeast experienced the greatest reductions in cataract surgery (-27.9%; 99% CI, -32.8% to -22.3%). CONCLUSIONS AND RELEVANCE: These results show that the COVID-19 pandemic caused a notable drop in the number of common ophthalmic procedures among Medicare beneficiaries, especially in laser peripheral iridotomy, while eye drug injections saw minimal changes. The Northeast experienced the largest reductions, highlighting the pandemic's association with changes in eye care and indicating a need for focused recovery efforts in the hardest hit areas.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mahmoudzadeh R, Samuel M, Wheeler S, et al. COVID-19 Pandemic and Rates of Common Ophthalmic Procedures Among Medicare Beneficiaries. JAMA Ophthalmol. 2025. PMID: 39913155. doi:10.1001/jamaophthalmol.2024.6065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。